Raxibacumab, clinically designated as PAmAb ABthrax, represents a groundbreaking therapeutic approach for anthrax . This engineered antibody , designed by the company , uniquely interacts with the https://raxibacumabantiprotectiv218433.blog5.net/94989824/raxibacumab-a-in-depth-investigation-into-the-p-antim-abab-anthrax